While the assessment of HR status in CTCs is a promising approach that could allow for the detection of HR heterogeneity in BC patients, a relationship between ERα expression in CTCs and the presence of specific metastatic sites have not been elucidated yet. This evidence concerns the gene ESR1 and breast cancer.